These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3044374)

  • 1. The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis. A long-term open study.
    Marcolongo R; Mathieu A; Pala R; Giordano N; Fioravanti A; Panzarasa R
    Arthritis Rheum; 1988 Aug; 31(8):979-83. PubMed ID: 3044374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B
    Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin in the treatment of juvenile rheumatoid arthritis.
    Giannini EH; Brewer EJ; Person DA
    J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
    Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
    Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis.
    Dequeker J; Gevers G
    Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A further possible cause of diarrhoea caused by oral gold.
    Cook NJ; Owen ET; Donlon JB
    Br J Rheumatol; 1995 Apr; 34(4):395-6. PubMed ID: 7788162
    [No Abstract]   [Full Text] [Related]  

  • 9. Auranofin therapy in juvenile rheumatoid arthritis: a 48-week phase II study.
    Kvien TK; Høyeraal HM; Sandstad B; Kass E
    Scand J Rheumatol Suppl; 1986; 63():79-83. PubMed ID: 3474778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of auranofin: a review of clinical experience.
    Blodgett RC; Pietrusko RG
    Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research)].
    Kuz'mina NN; Brue E; Shaĭkov AV; Isaeva LA; Shakhbazian IE; Giannini E; Iakovleva AA; Puodzhiunene EP; Vorontsov IM; Astrauskene DS
    Ter Arkh; 1990; 62(5):38-41. PubMed ID: 2204140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No firm basis to advocate auranofin in the treatment of juvenile rheumatoid arthritis.
    Criswell LA; Katz PP; Tack BB
    Arthritis Rheum; 1991 Jul; 34(7):934-5. PubMed ID: 1898455
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
    Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
    Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group.
    van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE
    Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
    Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D
    J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm auranofin therapy in patients with juvenile rheumatoid arthritis.
    Giannini EH; Brewer EJ; Person DA; He XH
    J Rheumatol; 1986 Aug; 13(4):768-70. PubMed ID: 3534260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.